Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment.

Elliott SP, Adejoro OO, Konety BR, Jarosek SL, Dusenbery KE, Virnig BA.

J Urol. 2012 Apr;187(4):1253-8. doi: 10.1016/j.juro.2011.11.088. Epub 2012 Feb 14.

PMID:
22335868
2.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.

J Urol. 2001 Sep;166(3):876-81. Erratum in: J Urol 2001 Nov;166(5):1839.

PMID:
11490237
3.

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.

Forsythe K, Blacksburg S, Stone N, Stock RG.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16.

PMID:
22099032
4.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

PMID:
15913914
5.

Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.

Sher DJ, Neville BA, Chen AB, Schrag D.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e197-206. doi: 10.1016/j.ijrobp.2011.02.007. Epub 2011 May 17.

PMID:
21596483
6.

Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.

Zelefsky MJ, Kattan MW, Fearn P, Fearon BL, Stasi JP, Shippy AM, Scardino PT.

Urology. 2007 Aug;70(2):283-7.

PMID:
17826490
7.

Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.

Khanna A, Hu JC, Gu X, Nguyen PL, Lipsitz S, Palapattu GS.

J Urol. 2013 Jan;189(1):75-9. doi: 10.1016/j.juro.2012.08.181. Epub 2012 Nov 16.

PMID:
23164382
8.
10.

Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y, Hoffman KE, Hu JC.

J Clin Oncol. 2011 Apr 20;29(12):1517-24. doi: 10.1200/JCO.2010.31.1217. Epub 2011 Mar 14.

11.

Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

Lips I, Dehnad H, Kruger AB, van Moorselaar J, van der Heide U, Battermann J, van Vulpen M.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):656-61. Epub 2007 May 23.

PMID:
17512127
12.

Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.

Kupelian PA, Reddy CA, Carlson TP, Altsman KA, Willoughby TR.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):904-12.

PMID:
12095556
13.

Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.

Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS.

J Urol. 2015 Aug;194(2):378-85. doi: 10.1016/j.juro.2015.02.084. Epub 2015 Feb 21.

14.

Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy.

Goldin GH, Sheets NC, Meyer AM, Kuo TM, Wu Y, Stürmer T, Godley PA, Carpenter WR, Chen RC.

JAMA Intern Med. 2013 Jun 24;173(12):1136-43. doi: 10.1001/jamainternmed.2013.1020.

PMID:
23689844
15.

Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.

Zelefsky MJ, Yamada Y, Kollmeier MA, Shippy AM, Nedelka MA.

Eur Urol. 2008 Jun;53(6):1172-9. doi: 10.1016/j.eururo.2007.12.030. Epub 2007 Dec 31.

PMID:
18222596
16.

External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?

Choe KS, Jani AB, Liauw SL.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):755-60. doi: 10.1016/j.ijrobp.2009.02.026. Epub 2009 May 20.

PMID:
19464123
17.

Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9. doi: 10.1016/j.ijrobp.2007.11.044.

PMID:
18313526
18.
19.

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Sheets NC, Goldin GH, Meyer AM, Wu Y, Chang Y, Stürmer T, Holmes JA, Reeve BB, Godley PA, Carpenter WR, Chen RC.

JAMA. 2012 Apr 18;307(15):1611-20. doi: 10.1001/jama.2012.460.

20.

Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan.

Nakamura K, Akimoto T, Mizowaki T, Hatano K, Kodaira T, Nakamura N, Kozuka T, Shikama N, Kagami Y.

Jpn J Clin Oncol. 2012 Jan;42(1):53-7. doi: 10.1093/jjco/hyr175. Epub 2011 Nov 30.

PMID:
22131339

Supplemental Content

Support Center